Odyssey Therapeutics, Inc. (ODTX) stock
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$19.37+0.01 (+0.05%)
Close on Nov 17, 2026Market cap $930.89MP/E –Yield –
Odyssey Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.51M | – |
| Q1 FY2026 | Mar 31, 2026 | -$41.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$34.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$38.62M | – |
See a number that looks wrong?